Tirzepatide achieves an average reduction of 22.5%, while retatrutide shows early indications of up to 24.2%
These drugs can suppress appetite and slow digestion, so focusing on nutrient-dense and balanced meals is essential to avoid nutrient deficiencies
Pure GIP agonists, when tested without GLP-1 agonism, havent shown impressive weight loss results in early studies
Food noise often quiets within one to two weeks, sometimes at the 0.25 mg starter and before the scale moves
The fastest providers (Hims, Ro) can complete evaluations and prescribe within 24 hours for straightforward cases
Psychoneuroendocrinology 65, 5466.CrossRefGoogle ScholarPubMed Aroda, VR (2018) A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials